Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 19 '25)

Image
By G.M.

 


    Biochem Biophys Res Commun

  1. DU S, Yang L, Chen X, Chen Y, et al
    Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants.
    Biochem Biophys Res Commun. 2025;746:151224.
    PubMed         Abstract available


    BMC Pediatr

  2. YANG SI, Choi CH, Lee EJ, Jee SH, et al
    Impact of pediatric COVID-19 isolation on children's well-being and caregiver mental health.
    BMC Pediatr. 2025;25:37.
    PubMed         Abstract available


    Epidemiol Infect

  3. NOSTAEVA A, Shimansky V, Apalko S, Kuznetsov I, et al
    Case-control association study between polygenic risk score and COVID-19 severity in a Russian population using low-pass genome sequencing.
    Epidemiol Infect. 2024;153:e13.
    PubMed         Abstract available


    J Infect

  4. RJOOB K, Antonelli M, Murray B, Molteni E, et al
    Symptom Evolution in Individuals with Ongoing Symptomatic COVID-19 and Post COVID-19 Syndrome After SARS-CoV-2 Vaccination Versus Influenza Vaccination.
    J Infect. 2025 Jan 10:106406. doi: 10.1016/j.jinf.2024.106406.
    PubMed         Abstract available


    J Virol

  5. FOO IJH, Chua BY, Chang SY, Jia X, et al
    Prior influenza virus infection alleviates an arbovirus encephalitis by reducing viral titer, inflammation, and cellular infiltrates in the central nervous system.
    J Virol. 2025 Jan 16:e0210824. doi: 10.1128/jvi.02108.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  6. PAPA A, Barile JP, Jia H, Thompson WW, et al
    Gaps in Mental Health Care-Seeking Among Health Care Providers During the COVID-19 Pandemic - United States, September 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2025;74:19-25.
    PubMed         Abstract available


    N Engl J Med

  7. HALL VG, Smibert OC, Sullivan SG, Lim C, et al
    Influenza Vaccination Strategies in Patients with Hematologic Cancer.
    N Engl J Med. 2025;392:306-308.
    PubMed        


    PLoS Comput Biol

  8. BOTTCHER L, D'Orsogna MR, Chou T
    Aggregating multiple test results to improve medical decision-making.
    PLoS Comput Biol. 2025;21:e1012749.
    PubMed         Abstract available

  9. BADROU A, Mariano CA, Ramirez GO, Shankel M, et al
    Towards constructing a generalized structural 3D breathing human lung model based on experimental volumes, pressures, and strains.
    PLoS Comput Biol. 2025;21:e1012680.
    PubMed         Abstract available


    PLoS One

  10. SUMI A, Koyama M, Katagiri M, Ohtomo N, et al
    Spectral study of COVID-19 pandemic in Japan: The dependence of spectral gradient on the population size of the community.
    PLoS One. 2025;20:e0314233.
    PubMed         Abstract available

  11. GANTENBERG JR, Thompson KD, van Aalst R, Smith DM, et al
    Inpatient service utilization amongst infants diagnosed with Respiratory Syncytial Virus infection (RSV) in the United States.
    PLoS One. 2025;20:e0317367.
    PubMed         Abstract available

  12. KIM WH, Kim J, Oh J, Lee S, et al
    Unexpected effects of pandemic-related changes on mental health: Evidence from a nationwide survey in South Korea.
    PLoS One. 2025;20:e0317493.
    PubMed         Abstract available

  13. THAPALIYA K, Marshall-Gradisnik S, Eaton-Fitch N, Barth M, et al
    Hippocampal subfield volume alterations and associations with severity measures in long COVID and ME/CFS: A 7T MRI study.
    PLoS One. 2025;20:e0316625.
    PubMed         Abstract available

  14. OKWUMABUA O, Bradley-Siemens N, Cruz C, Chittick L, et al
    Detection of SARS-CoV-2 and a possible variant in shelter cats.
    PLoS One. 2025;20:e0317104.
    PubMed         Abstract available

  15. TAN H, Xiao W
    The mediating role of core self-evaluation in the association between perceived peer relationship quality and loneliness in university students.
    PLoS One. 2025;20:e0317310.
    PubMed         Abstract available

  16. BLAKE H, Hassard J, Thomson L, Choo WH, et al
    Psychological detachment from work predicts mental wellbeing of working-age adults: Findings from the 'Wellbeing of the Workforce' (WoW) prospective longitudinal cohort study.
    PLoS One. 2025;20:e0312673.
    PubMed         Abstract available

  17. AUTIER P, Doi G, Mullie P, Vankrunkelsven P, et al
    Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials.
    PLoS One. 2025;20:e0303316.
    PubMed         Abstract available

  18. WARTINI-TWARDOWSKA J, Twardowska NP
    A twofold perspective on the quality of research publications: The use of ICTs and research activity models.
    PLoS One. 2025;20:e0308952.
    PubMed         Abstract available

  19. WEISHAAR H, Evans M, Chemali S, Maray EM, et al
    The importance of organisational culture for health system resilience: A qualitative analysis of factors that supported health care workers in Germany during the COVID-19 pandemic.
    PLoS One. 2025;20:e0317231.
    PubMed         Abstract available

  20. BRUGNOLI E, Delmastro M
    Dynamics and triggers of misinformation on vaccines.
    PLoS One. 2025;20:e0316258.
    PubMed         Abstract available

  21. ALEXANDER N, Dye C, Busch MP, Buss L, et al
    Dynamics of SARS-CoV-2 infection over two epidemic waves in Manaus, Brazil: A serological study of seven thousand blood donors.
    PLoS One. 2025;20:e0308319.
    PubMed         Abstract available

  22. SULLIVAN J, Moss-Racusin C, Louis K
    Masking is good, but conforming is better: The consequences of masking non-conformity within the college classroom.
    PLoS One. 2025;20:e0312392.
    PubMed         Abstract available

  23. POKHILENKO I, Frew E, Murphy M, Pallan M, et al
    Impact of the COVID-19 lockdown in the United Kingdom on adolescent's time use (CONTRAST study).
    PLoS One. 2025;20:e0310597.
    PubMed         Abstract available

  24. KUO LT, Tsai SL, Dave U, Marmor WA, et al
    Exploring mental health symptoms in elite athletes during the COVID-19 pandemic: A systematic review and meta-analysis on sex differences.
    PLoS One. 2025;20:e0314996.
    PubMed         Abstract available

  25. CARD-GOWERS J, Boniface S, Brown J, Kock L, et al
    Long-term health consequences and costs of changes in alcohol consumption in England during the COVID-19 pandemic.
    PLoS One. 2025;20:e0314870.
    PubMed         Abstract available

  26. PAPLA D, Siedlecki R
    Analysis of entropy on the European markets of energy and energy commodities prices.
    PLoS One. 2025;20:e0315348.
    PubMed         Abstract available

  27. MINASSIE BB, Degu WA, Etissa EK, Asfeha NF, et al
    Attributes and factors associated with long covid in patients hospitalized for acute COVID-19: A retrospective cohort study.
    PLoS One. 2025;20:e0317512.
    PubMed         Abstract available

  28. AVADHANULA V, Creighton CJ, Ferlic-Stark L, Nagaraj D, et al
    Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load.
    PLoS One. 2025;20:e0317033.
    PubMed         Abstract available

  29. PALMA D, Guillaumes M, Pericas C, de Andres A, et al
    A new STI in the city: MPOX in Barcelona. First outbreak (5/2022-5/2023) and subsequent resurgence.
    PLoS One. 2025;20:e0296141.
    PubMed         Abstract available

  30. JAMBOR E, Viana J, Reuter-Oppermann M, Muller-Polyzou R, et al
    Evaluating the impact of COVID-19 protection measures and staff absence on radiotherapy practice: A simulation study.
    PLoS One. 2025;20:e0314190.
    PubMed         Abstract available

  31. MILLER D, Dziulko A, Levy S
    Pooled PPIseq: Screening the SARS-CoV-2 and human interface with a scalable multiplexed protein-protein interaction assay platform.
    PLoS One. 2025;20:e0299440.
    PubMed         Abstract available

  32. VIDAL-MARTINEZ VM, Mancilla-Tapia JM, Soler-Jimenez LC, Velazquez-Abunader I, et al
    At what cycle threshold level are dogs able to detect SARS-CoV-2 in humans?
    PLoS One. 2025;20:e0317213.
    PubMed         Abstract available

  33. RICKARDSSON J, Mellander C
    The impact of health risk communication on self-perceived health and worry of targeted groups: Lessons from the Swedish COVID-19 response.
    PLoS One. 2025;20:e0311596.
    PubMed         Abstract available

  34. SONG A, Chao T, Harris B, Hsin H, et al
    The impact of shelter-in-place during the COVID-19 pandemic on social support for mental health recovery: A prescribing-oriented qualitative study of patient perspectives.
    PLoS One. 2025;20:e0316582.
    PubMed         Abstract available

  35. BARCA L, Iodice P, Chaigneau A, Lancia G, et al
    Emotional distress and affective knowledge representation one year after the COVID-19 outbreak.
    PLoS One. 2025;20:e0311009.
    PubMed         Abstract available


    Vaccine

  36. HONDA-OKUBO Y, Vaghasiya U, Petrovsky N
    Immunogenicity in mice and non-human primates of an Advax-CpG55.2-adjuvanted recombinant hemagglutinin seasonal quadrivalent influenza vaccine.
    Vaccine. 2025;47:126707.
    PubMed         Abstract available

  37. FREY SE, Brady R, Jackson L, Goepfert P, et al
    Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59(R).
    Vaccine. 2025;47:126702.
    PubMed         Abstract available


    Virology

  38. LV X, Zheng T, Lei X, Ren L, et al
    RTP4 restricts influenza A virus infection by targeting the viral NS1 protein.
    Virology. 2025;603:110397.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »